J and J hid studies showing
its Risperdal anti-psychotic drug caused diabetes to protect
billions of dollars in sales, a lawyer said in the first
personal-injury claim over the medication to go to trial.
Researchers at J&J’s Janssen unit knew as early as 1999
that a study found Risperdal caused diabetes at a higher rate
than a competing drug and failed to hand over the results to
regulators probing links between the disease and anti-psychotic